• PND12 Vagus Nerve Stimulation Versus ANTI-Epileptic Drug in Chinese Patients with Drug-Resistant Epilepsy: A Cost–Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN91 Penetration of Artificial Intelligence (AI) and Machine Learning (ML) in the Randomized Controlled Setting of Oncology

    Sep 1, 2020, 00:00

  • PUK5 Remaining Waitlisted for a Superior Quality Kidney; An Economic Evaluation of Contemporary Transplant Practice

    Sep 1, 2020, 00:00

  • PMH7 Depression and Insomnia at Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PNS65 Comparison of Quality of Life and Burden of Lower Back PAIN Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

    Sep 1, 2020, 00:00

  • PIN13 Clinicoeconomic IMPACT of an Alcohol Based Hand RUB to Reduce Gram Negative MULTI Drug Resistant Bacteria: A Simulation Study in an Indian Healthcare Setting

    Sep 1, 2020, 00:00

  • PCN39 Cost-Effectiveness of Brentuximab Vedotin for Relapsed or Refractory Systemic Anaplastic Large-CELL Lymphoma in China

    Sep 1, 2020, 00:00

  • PMU7 Drug-Drug Interaction ( DDI ) Pharmacoeconomic Studies of Waste. Experience of a Single Institution Based on Rwd at a Private Health Insurance in LATAM

    Sep 1, 2020, 00:00

  • PDG14 Evaluating Accessibility of Essential Medicines in Indonesia: A Survey on Availability and Price in Public and Private Health Sectors

    Sep 1, 2020, 00:00

  • PMD4 Analysis of Costs, Length of Hospital STAY (LOS), Readmission and Quality of Life in Patients Undergoing Primary TOTAL Knee Arthroplasty (TKA) from China ATTUNE® Study

    Sep 1, 2020, 00:00

  • PCN86 Predicting the Unknown - How Health Technology Assessment Agencies Deal with Uncertainty, and the IMPACT This HAS on Patient Access for Immuno-Oncology Therapies

    Sep 1, 2020, 00:00

  • PIN20 Study on Disease Treatment Preference and Willingness Payment in Hepatitis C Patients

    Sep 1, 2020, 00:00

  • PDB20 Clinical Outcomes Among Patients with Hyperkalemia in China: A Population-Based Retrospective Study

    Sep 1, 2020, 00:00

  • PND24 Target Identification and Drug Repurposing for Parkinson's Disease: A NOVEL Integrative Computational Approach

    Sep 1, 2020, 00:00

  • PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran

    Sep 1, 2020, 00:00

  • PCN8 Real World Treatment Patterns, Healthcare Resource Utilization (HCRU), Economic Outcomes and Survival Associated with Esophageal Cancer in JAPAN

    Sep 1, 2020, 00:00

  • PMU13 Defining the ROLL out Strategy for UHC Benefits: Philhealth's Benefit Development PLAN

    Sep 1, 2020, 00:00

  • PMD2 The Relationship between Sedatives and Risk of Ventilator-Associated Events

    Sep 1, 2020, 00:00

  • PMS4 Epidemiology, Treatment Patterns, and Economic Burden of Postmenopausal Osteoporosis and Associated Fractures in China in 2017

    Sep 1, 2020, 00:00

  • PSS4 Disease Burden of Rvo-ME in China – a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PMH1 MODEL Based Pharmacoeconomic Evaluation of Medication for Depression Disorder: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS48 The Analysis of Sources of Utility Values USED in Cost-Utility Analyses in China

    Sep 1, 2020, 00:00

  • PCN24 Budget IMPACT Analysis (BIA) of Introducing Tisagenlecleucel for the Treatment of Patients with Relapsed and Refractory Diffuse Large B-CELL Lymphoma (R/R DLBCL) in Singapore (SG)

    Sep 1, 2020, 00:00

  • PND17 The Burden and IMPACT of Migraine in the Philippines: An Analysis of Survey DATA Among Employed Population

    Sep 1, 2020, 00:00

  • PCN5 Real-World Incidence and Management of Adverse Events (AE) in Patients with NON-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide

    Sep 1, 2020, 00:00

  • PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries

    Sep 1, 2020, 00:00

  • PCN53 Cost-Utility Analysis of Dacomitinib As First-LINE Treatment for Patients with Locally Advanced or Metastatic NON-SMALL CELL LUNG Cancer in China

    Sep 1, 2020, 00:00

  • PUK10 Treatment Patterns in Patients with Metastatic Renal Cell Carcinoma Receiving Second Line Targeted Therapy: Real-World Data from a Retrospective Study in Taiwan

    Sep 1, 2020, 00:00

  • PMS1 Economic Outcomes of Ankylosing Spondylitis Patients Initiating Biologic Therapy in Taiwan - a Population-Based Analysis

    Sep 1, 2020, 00:00

  • PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis

    Sep 1, 2020, 00:00

  • PCN13 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus S-1 PLUS Gemcitabine in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN31 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment for Patients with HER2-Positive EARLY Breast Cancer: Update Results after National Drug Rei ...

    Sep 1, 2020, 00:00

  • PDG19 Status of Published Pharmacoeconomic Evidence on Monoclonal Antibodies Reimbursed in China

    Sep 1, 2020, 00:00

  • PCN46 Disease Burden of Chronic Lymphocytic Leukemia/SMALL Lymphocytic Lymphomaunder Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCV11 Cost-Effectiveness of Intravascular Ultrasound (IVUS) during Drug-Eluting Stent Implantation in Korea

    Sep 1, 2020, 00:00

  • PCN63 A Frequency of ORAL Mucositis in Patients with Breast and Gynecological Cancers

    Sep 1, 2020, 00:00

  • PCV18 Risk Prediction Models for in-Hospital Mortality in ACUTE Aortic Dissection: A Systematic Review

    Sep 1, 2020, 00:00

  • PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients

    Sep 1, 2020, 00:00

  • PCN58 Frequency of Myalgia in Patients Receiving Platinum Based Chemotherapy

    Sep 1, 2020, 00:00

  • Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel

    Sep 1, 2020, 00:00

  • PNS52 Valuating Pharmaceutical Innovations Beyond Qalys: A Comprehensive Analysis of VALUE-Based Pricing Models

    Sep 1, 2020, 00:00

  • PNS69 Measuring and Valuing Patient Experience

    Sep 1, 2020, 00:00

  • PDB29 Diagnostic and Prognostic VALUE of Galectin-3 and GDF-15 in Diabetic Nephropathy Patients

    Sep 1, 2020, 00:00

  • PCN12 Explore-LC: Uniting Existing Real-World DATA Sources to Create a NOVEL ASIA-Pacific Wide Research Platform for NON-SMALL CELL LUNG Cancer

    Sep 1, 2020, 00:00

  • Did You Get What You Wanted? Patient Satisfaction and Congruence Between Preferred and Perceived Roles in Medical Decision Making in a Hungarian National Survey

    Sep 1, 2020, 00:00

  • Barriers to Diabetes Adherence: Translation and Cultural Adaptation of the Instrument Into Arabic Context [Editor's Choice]

    Sep 1, 2020, 00:00

  • PIH12 COMPARISON OF THE POST-MARKET UTILIZATION PATTERNS OF ALZHEIMER'S DISEASE TREATMENTS BETWEEN SOUTH KOREA AND AUSTRALIA: TIME TO CONSIDER REASSESSMENT OF COST-EFFECTIVENESS

    Sep 1, 2020, 00:00

  • PNS44 Health Sector Budgetary Allocations and Their Implications on Health Service Delivery and UHC in Uganda: What CAN Members of Parliament Do?

    Sep 1, 2020, 00:00

  • PRS21 The Complexity and Medical Resources for COPD Patients in China

    Sep 1, 2020, 00:00

  • PDG5 Cost- Effectiveness Analysis between Aprepitant and Fosaprepitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China

    Sep 1, 2020, 00:00

  • Knowledge and Attitude of Physicians Towards the Cost of Commonly Prescribed Medicines: A Case Study in Three Nigerian Healthcare Facilities

    Sep 1, 2020, 00:00

  • PCN94 Health-Related Quality of Life Among Breast Cancer Patients and Survivors in Vietnam

    Sep 1, 2020, 00:00

  • PND4 Exploratory Cost-Effectiveness Analysis of Thread Embedding Acupuncture Plus Usual Care Versus Usual Care Alone for Treating Sequelae in Bell's Palsy Patients: An Economic Evaluation Alongside a Clinical Trial

    Sep 1, 2020, 00:00

  • PIN3 Is Dolutegravir Cost Effective in Treating Patients Living with HIV?

    Sep 1, 2020, 00:00

  • PCN22 Cost-Effectiveness of Pembrolizumab PLUS Axitinib Versus Nivolumab PLUS Ipilimumab As First-LINE Treatment of Advanced Renal CELL Carcinoma

    Sep 1, 2020, 00:00

  • PCN60 Frequency of Myalgia in Patients Receiving Taxane Chemotherapy

    Sep 1, 2020, 00:00

  • PNS39 History, Present, and Future of DRG-Based Payment Systems in EAST ASIA - Experience from South Korea, JAPAN, and Taiwan and the Introduction in China

    Sep 1, 2020, 00:00

  • PCN79 Willingness to Pay for Cancer Screening Testing in Malaysia

    Sep 1, 2020, 00:00

  • PCN81 The Role of Different Specialties in the Management of NON-SMALL CELL LUNG Cancer: Insights from a Real-World Study

    Sep 1, 2020, 00:00

  • PDB6 Cost-Effectiveness of Liraglutide Versus Insulin Glargine, BOTH in Combination with Metformin for Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • List of Reviewers

    Sep 1, 2020, 00:00

  • PIN12 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 70 YEARS and Older in Australia

    Sep 1, 2020, 00:00

  • PCV17 Systematic Literature Review of Cardiovascular Risk Factor Management in 11 Asian Markets

    Sep 1, 2020, 00:00

  • PMS10 The Health Economics Analyses of TOTAL HIP Arthroplasty: A Literature Review

    Sep 1, 2020, 00:00

  • PDG9 Cost Effectiveness Analysis of Blonanserin Versus Olanzapine As First-LINE Treatment for Patients with Schizophrenia in China

    Sep 1, 2020, 00:00

  • PAM6 Cost IMPACT Analysis for Coated VS NON-Coated CVC in China

    Sep 1, 2020, 00:00

  • PCN61 Frequency of Myalgia in Patients with Gynecological Cancer

    Sep 1, 2020, 00:00

  • PIN1 Risk of Breastfeeding Newborns By Hbsag and Hbeag Positive Mothers: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCV4 Review On:-Cardiovascular Risk Reduction With Icosapent Ethyl For Hypertriglyceridemia

    Sep 1, 2020, 00:00

  • PMU29 Real World DATA Availability and Quality in ASIA Pacific. Assessment and Implications for Research and Healthcare Decision-Making

    Sep 1, 2020, 00:00

  • PCV27 Assessment of Health Related Quality of Life Among Adherent and NON-Adherent Medication Group of Coronary Artery Disease Patients

    Sep 1, 2020, 00:00

  • PND15 The Health and Productivity Burden of Migraines in Australia

    Sep 1, 2020, 00:00

  • PMH13 Children with Computer GAME Addiction Benefit from Visuospatial Training

    Sep 1, 2020, 00:00

  • PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19

    Sep 1, 2020, 00:00

  • PRO10 Income LEVEL Shift of RARE Disease Patients in South Korea

    Sep 1, 2020, 00:00

  • PCN69 The IMPACT of Patient Access Schemes for Innovative Cancer Therapies in FOUR Asian Countries: A MIXED-Method Review

    Sep 1, 2020, 00:00

  • PBI7 Comparison of Biosimilar Policies between Key Countries in ASIA, EU and USA

    Sep 1, 2020, 00:00

  • PCN6 Thromboembolic Events Among Cancer Patients Treated with Chemotherapy at Adult Oncology Unit of Tikur Anbessa Specialized Hospital: A Retrospective CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PSU11 Trends in the Adoption of Minimally Invasive Partial Nephrectomy in South Korea

    Sep 1, 2020, 00:00

  • PDB13 The Cost-Effectiveness of Diabetes Prevention Programmes in Bangladesh

    Sep 1, 2020, 00:00

  • PMH3 Desogestrel: Does IT Cause Severe Psychiatric Disorders, a Retrospective Analysis of FDA Adverse Event Reporting System and Eudravigilance

    Sep 1, 2020, 00:00

  • PBI1 Comparison of the Combination of Recombinant Follicle-Stimulating Hormone and Recombinant Luteinizing Hormone Protocol Versus Human Menopausal Gonadotropin Protocol in Controlled Ovarian Stimulation: A Systematic Review and Meta-Analys ...

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PND16 Quantifying the Burden of Migraine in JAPAN: A Propensity-Score Matched Analysis of a Population-Based Survey

    Sep 1, 2020, 00:00

  • PCN21 Disease Burden of Multiple Myeloma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMU5 Costs and Health Outcomes of Korean Children Attributable to Secondhand Smoke Exposure at HOME: An Analysis By a Markov MODEL

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PNS11 Changes in the Latest Chinese Guidelines for Pharmacoeconomic Evaluations

    Sep 1, 2020, 00:00

  • PDG3 Comparison of Pharmacoeconomic Evaluation Guidelines in Korea, JAPAN and China

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • PDG22 Comparison of Healthcare Systems and Opportunities for Innovative Drugs across India, Vietnam, and Indonesia

    Sep 1, 2020, 00:00

  • PIH7 Cost of Illness of Inpatient Pediatric Pneumonia Patients Hospitalized in Yogyakarta Indonesia

    Sep 1, 2020, 00:00

  • PIH3 Pharmacoeconomic Evaluation of ORAL Ibuprofen Versus Intravenous Ibuprofen in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Units in Qatar

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • Making Connections and Measuring Performance: Bibliometric Analysis of Multi-Attribute, Preference-Based Health-Related Quality of Life Research in South Africa

    Sep 1, 2020, 00:00

  • PNS46 Exploration of the Weight-Loss Management Service at Community Pharmacy in Malaysia

    Sep 1, 2020, 00:00

  • Assessing Patient Knowledge of Asthma Using a Newly Validated Tool

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • Editorial Board

    Sep 1, 2020, 00:00

  • PIN11 Budget IMPACT of the National AIDS PLAN Recommended Guidelines for Preferent NO Coformulated Initial Antiretroviral Therapy in Naïve HIV-Infected Adults in Mexico in 2020

    Sep 1, 2020, 00:00

  • PSU4 Cost Comparison and Budget IMPACT MODEL for Radical Prostatectomy in England

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • PIN41 Economic Burden of 2009 Pandemic H1N1 Influenza in Mainland China: A Systematic Review and Modelling Study

    Sep 1, 2020, 00:00

  • PIH5 Clinical and Economic Evaluation of ORAL Versus Intravenous Ibuprofen Therapy in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Unit in Qatar

    Sep 1, 2020, 00:00

  • PCN87 Key Clinical and Economic Rationales for Oncology Reviews in South Korea

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • PNS33 Developing and Adopting Regulatory Scien Experiences of Drug Regulatory Authorities in China, United States, European Union, and JAPAN

    Sep 1, 2020, 00:00

  • PMS3 Calibration of a Cost-Effectiveness MODEL for Systemic LUPUS Erythematosus Using NEWLY Observed LONG-TERM Organ Damage DATA

    Sep 1, 2020, 00:00

  • PSY1 Medication Trends and Medical Costs Among Patients with Rheumatoid Arthritis on Biologics Treatment in Taiwan: A 6-Year Cohort Study Using a National Claims Database

    Sep 1, 2020, 00:00

  • PND22 Application of Therapeutic Plasma Exchange in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PDG21 Risk-Sharing Agreements: Experience That China Could Learn from European and Other EAST-Asian Countries

    Sep 1, 2020, 00:00

  • PCN85 Comparison of Observed LONG-TERM Overall Survival with Extrapolated Overall Survival for Pembrolizumab Monotherapy Assessed By Australian Reimbursement Authorities

    Sep 1, 2020, 00:00

  • PRS17 Barriers to and Competency with the Use of Metered Dose Inhaler and Its IMPACT on Disease Control Among Adult Asthmatic Patients in Ethiopia

    Sep 1, 2020, 00:00

  • PBI5 Future Trends on the Biosimilar Uptake in China, JAPAN, the US, the EU4 and the UK

    Sep 1, 2020, 00:00

  • PCN40 Cost-Utility Analysis of Pembrolizumab Versus Platinum Based Chemotherapy As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer (NSCLC) in UK

    Sep 1, 2020, 00:00

  • PNS73 Retrospective Study for Comorbidities in ACTIVE Population Using Japanese Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PCN20 Comparison of Nab-paclitaxel PLUS Gemcitabine Versus FOLFIRINOX in First LINE Treatment of Metastatic Pancreatic Cancer in China: A Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PND2 A Meta-Analysis of Efficacy and Safety of Vesicular Monoamine Transporter Type 2 Inhibitors for Treatment of Huntington Chorea

    Sep 1, 2020, 00:00

  • PRS11 Comparison of Health-Related Quality of Life for Adult Patients with Asthma in ASIA and the U.S

    Sep 1, 2020, 00:00

  • A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population [Editor's Choice]

    Sep 1, 2020, 00:00

  • PRS19 Use of Patient Reported Outcomes in Asthma Product Development in JAPAN: A Review of Labeled Products

    Sep 1, 2020, 00:00

  • PCN51 Disease Burden of Mantle CELL Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIH10 Estimating Economic Burden of CHILD Asthma Attributing to Exposure to PM2.5 in JAPAN

    Sep 1, 2020, 00:00

  • PRO2 Economic Evaluation of Reproductive Carrier Screening for Recessive Genetic Conditions: A Systematic Review

    Sep 1, 2020, 00:00

  • PRS18 The IMPACT of Idiopathic Pulmonary Fibrosis on Health State Utility Values: Evidence from Australia

    Sep 1, 2020, 00:00

  • PDB16 Identifying Prevalence and Risk Factors of Poor Glycemic Control Among Diabetic Patients in a Central RURAL Province of Saudi Arabia

    Sep 1, 2020, 00:00

  • PNS45 Research On Comprehensive Evaluation Index System Of Economic Operation Of Public Hospitals In China

    Sep 1, 2020, 00:00

  • Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece

    Sep 1, 2020, 00:00

  • PIH19 Inequality of Access to Minimally Invasive Hysterectomy for Patients with Endometrial Cancer in South Korea

    Sep 1, 2020, 00:00

  • PCV29 Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions

    Sep 1, 2020, 00:00

  • PND18 The Impact Of Anxiety Caused By Pharmacy Licence Examination Core Competency Of Fourth Year Pharmacy Students Of Burapha University 2018

    Sep 1, 2020, 00:00

  • PRO7 Economic Burden of Pompe Disease in China: Empirical Evidences and Simulation of Policy Effects

    Sep 1, 2020, 00:00

  • PMU4 Budget IMPACT Analysis of FLOW Cytometry Application in EARLY Diagnosing of Patients with Primary Immunodeficiency Diseases in China

    Sep 1, 2020, 00:00

  • PRO11 Policy Initiatives to Facilitate the Patient Access to Orphan Drugs in China

    Sep 1, 2020, 00:00

  • PCV32 Clinical Utilization of Antiplatelets and Anticoagulants in ACUTE Coronary Syndrome Patients - a Single-Centered Observational Study in Hong Kong

    Sep 1, 2020, 00:00

  • PCN89 Constructing Comparator Survival DATA: Simulated Versus Individual Patient DATA

    Sep 1, 2020, 00:00

  • PCN16 Treatment Cost in Patients with Relapsed Refractory Multiple Myeloma in JAPAN

    Sep 1, 2020, 00:00

  • PRS10 Impact of Tobacco Smoking before Pregnancy on Quality of Life of Pregnant Women: A National Cross-Sectional Study

    Sep 1, 2020, 00:00

  • PCN34 The Societal IMPACT of Obinutuzumab in the First-LINE Treatment of Follicular Lymphoma in China

    Sep 1, 2020, 00:00

  • PCN68 Real-World Cardiac Safety of Systemic Therapies for HER2+ Metastatic Breast Cancer in Older Versus Younger Patients: A Retrospective Cohort Study Using Electronic Health Record DATA and Cancer Registries

    Sep 1, 2020, 00:00

  • PMU12 How Are Quarantine Impacting on the Health-Related Quality of Life?

    Sep 1, 2020, 00:00

  • PNS3 Managed Entry Agreements: The European Experience and the Potential in JAPAN

    Sep 1, 2020, 00:00

  • PDG7 Cost Minimization Analysis of Dexamethasone Intravitreal Implant and Ranibizumab for Rvo-Macular Edema in China

    Sep 1, 2020, 00:00

  • PCV26 Quality of Life Improves More for People Who Receive Proactive Absolute Cardiac Risk Management in a Rapid Access Chest Pain Clinic Compared to Usual Care

    Sep 1, 2020, 00:00

  • PNS41 Preferences of Older Patients with Chronic Diseases for Medication Review Services in Shanxi, China: Results from a Discrete Choice Experiment

    Sep 1, 2020, 00:00

  • PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

    Sep 1, 2020, 00:00

  • PMH4 The Psychological and Behavioral Responses to Covid-19 Epidemic in Pregnant Women in China: A Nationwide Survey

    Sep 1, 2020, 00:00

  • PSU13 The Cost-Effectiveness of I-Factor Compared to Local Autograft in Anterior Cervical Discectomy and Fusion Surgery

    Sep 1, 2020, 00:00

  • PCN99 What Is the IMPACT of Chemotherapy Induced Peripheral Neuropathy on Individuals and the Community?

    Sep 1, 2020, 00:00

  • PCV28 The EQ-5D-5L Is More Discriminative Than The EQ-5D-3L In Patients With Cardiovascular Diseases: A Multi-Ethnic Asian Study

    Sep 1, 2020, 00:00

  • PDG24 Private Primary Care Health Clinics in Malaysia and Uncontrolled Drug Pricing: Employer Health Insurance Coverage for Sustainable Reimbursement Drug Policy

    Sep 1, 2020, 00:00

  • PSS5 Disease Burden of Rvo-ME in China——a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PCN10 ORAL H2RA for Taxane Hypersensitivity Prevention: A Pharmacokinetic-Guided Decision

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • Evaluation of Psychometric Quality of EQ-5D-5L Scale for Assessing Health-Related Quality of Life of Malaria Patients

    Sep 1, 2020, 00:00

  • PMH10 Depression Severity Is Associated with Physical PAIN Severity across Countries

    Sep 1, 2020, 00:00

  • PNS37 Evalutaion of Time to Reimbursement for Rsa Drugs in Korea

    Sep 1, 2020, 00:00

  • PDG4 Cost-Utilities Analysis of First LINE Treatments on Advanced STAGE EGFR Positive in NON-SMALL CELL LUNG Cancer Patients in Taiwan

    Sep 1, 2020, 00:00

  • PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

    Sep 1, 2020, 00:00

  • PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries

    Sep 1, 2020, 00:00

  • PDB8 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Insulin Degludec in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PMH8 A DEEP Learning Approach for Predicting Onset of Depressive Disorder Using Health Insurance Claims DATA

    Sep 1, 2020, 00:00

  • PNS18 UNDER Threat of Covid-19, Is IT Against Humanitarianism to Adopt Sealed Management in Public Health Emergencies? a Survey Based on Chinese Public Attitudes Towards the Lockdown of Wuhan, China

    Sep 1, 2020, 00:00

  • PCN78 Cost Comparison of Administering ORAL Compared to Intravenous paclitaxel for Patients with Advanced Gastric Cancer in South Korea: A MICRO-Costing Study

    Sep 1, 2020, 00:00

  • PCN98 Assessment of Quality of Life in Patients with Metastatic Breast Cancer and Its Pharmaceutical Management in Tertiary Care Hospital: A Prospective Observational Study

    Sep 1, 2020, 00:00

  • PDG10 An Economic Evaluation of Tofacitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis in Singapore

    Sep 1, 2020, 00:00

  • PCV2 Volatile Anesthetics Versus TOTAL Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PDB28 A Real-World Effectiveness of Udca Added to Oha on Glycemic Control in Type 2 Diabetes Patients with LIVER Disease

    Sep 1, 2020, 00:00

  • PNS60 Use of Artificial Intelligence with Distillersr Software in Selected Systematic Literature Reviews

    Sep 1, 2020, 00:00

  • The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia

    Sep 1, 2020, 00:00

  • PIN34 Effects of Meteorological Factors on the Daily Domestic New CASES of Coronavirus Disease (COVID-19) in Asian Countries: A MULTI-Country Generalized Additive Modeling Analysis

    Sep 1, 2020, 00:00

  • PIN14 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 65 YEARS and Older in Korea

    Sep 1, 2020, 00:00

  • PCN44 Disease Burden of Follicular Lymphoma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS2 Voice Technology - an Opportunity to Broaden Participation in Patient Reported Outcomes Research

    Sep 1, 2020, 00:00

  • PMU20 Is There an Implicit Willingness-to-Pay Threshold in Singapore?

    Sep 1, 2020, 00:00

  • PIN43 IMPACT of CRE Infections on Hospital LOS and Mortality in ASIA

    Sep 1, 2020, 00:00

  • PCN29 Diagnosing and Classifying ACUTE Leukemia Patients through Immunophenotyping By FLOW Cytometry in Indonesia

    Sep 1, 2020, 00:00

  • PSS2 Modelling Disease Burden in Patients with Myopia in China in 2030

    Sep 1, 2020, 00:00

  • PCN66 Utilization of EGFR and ALK Testing in LUNG Cancer Patients Using Real Wrold DATA from China

    Sep 1, 2020, 00:00

  • PIN10 Cost IMPACT Analysis for Antibiotic Coated VS. NON-Coated Central Venous Catheters in India

    Sep 1, 2020, 00:00

  • PDB27 Association between Health Characteristics and Mode of Insulin Administration Among Patients with Type II Diabetes in 2017 China National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • PIN46 Predicting Invasive Candidiasis in Intensive Care Units

    Sep 1, 2020, 00:00

  • PNS66 Content Validation of Translated Clinical Outcome Assessments Is Important: Recommendations from Experience in Japan and China

    Sep 1, 2020, 00:00

  • PMU10 Representativeness of a National Patient-Reported Survey in Korea: The Korea National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • Copyright/Subscription

    Jun 3, 2020, 09:04

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • Assessing the Low Influenza Vaccination Coverage Rate Among Healthcare Personnel in India: A Review of Obstacles, Beliefs, and Strategies

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

    May 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »